Report of hereditary persistence of α-fetoprotein in a Spanish family: Molecular basis and clinical concerns

Journal of Hepatology

Volumn 38, Issue 4, 2003, Pages 541-544

  Blesa, José R ^a   Giner Durán, Remedios ^b   Vidal, José ^b   Lacalle, María L ^a   Catalán, Ignacio ^b   Bixquert, Miguel ^b   Igual, Lourdes ^b   Hernandez Yago, José ^a  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

Clinical diagnosis; Hepatocyte nuclear factor I; Hereditary persistence of fetoprotein; Tumor marker; Fetoprotein

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ANAMNESIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DNA FLANKING REGION; ECHOCARDIOGRAPHY; FAMILY STUDY; FEMALE; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC TRAIT; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER DISEASE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

EID: 0037385389     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00003-5     Document Type: Article

References (22)

1. Gitlin D, Perricelli A, Gitlin GM. Synthesis of AFP by liver, yolk sac and intestinal tract of the human conceptus. Cancer Res 1972;32:970-972.
2. Gitlin D, Boesman M. Serum α-fetoprotein, albumin and gG-globulin in the human conceptus. J Clin Invest 1966;45:1826-1838.
3. Van Furth R, Adinolfi M. In vitro synthesis of the fetal α1-globulin in man. Nature 1969;222:1296-1299.
4. Ball D, Rose E, Alpert E. Alpha-fetoprotein levels in normal adults. Am J Med Sci 1992;303:157-159.
5. Kobayashi K, Sugimoto T, Makino H, Kumagai M, Unoura M, Tanaka N, et al. Screening methods for early detection of hepatocellular carcinoma. Hepatology 1985;5:1100-1105.
6. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer 1989;56:660-666.
7. Perlin E, Engeler Jr JE, Edson M, Karp D, McIntire KR, Waldmann TA. The value of serial measurement of both human chorionic gonadotropin and alpha-fetoprotein for monitoring germinal cell tumors. Cancer 1976;37:215-219.
8. Van Tornout JM, Buckley JD, Quinn JJ, Feusner JH, Krailo MD, King DR, et al. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome. A report from the Children's Cancer Group. J Clin Oncol 1997;15:1190-1197.
9. Pitkanen S, Salo MK, Kuusela P, Holmberg C, Simell O, Heikinheimo M. Serum levels of oncofetal markers Ca 125, Ca 19-9, and alpha-fetoprotein in children with hereditary tyrosinemia type I. Pediatr Resp 1994;35:205-208.
10. Waldmann TA, McIntire KR. Serum alpha-fetoprotein levels in patients with ataxia-telangiectasia. Lancet 1972;2:1112-1115.
11. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992;327:588-593.
12. Ferguson-Smith MA, Rawlinson HA, May HM, Tait HA, Vince JD, Gibson AA, et al. Avoidance of anencephalic and spina bifida births by maternal serum-alphafetoprotein screening. Lancet 1978;1:1330-1333.
13. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-894.
14. Ferguson-Smith MA, May HM, O'Hare E, Aitken DA. Hereditary persistence of alphafetoprotein: a new autosomal dominant trait identified in an antenatal screening programme for spina bifida [abstract]. J Med Genet 1983;20:438.
15. McVey JH, Michaelides K, Hansen LP, Ferguson-Smith M, Tilghman S, Krumlauf R, et al. A G → A substitution in an HNF1 binding site in the human alpha-fetoprotein gene is associated with hereditary persistence of alpha-fetoprotein (HPAFP). Hum Mol Genet 1993;2:379-384.
16. Ferguson-Smith MA, May HM, Aitken DA, O'Hare E, Yates JRW, Gallagher J, et al. Hereditary persistence of α-fetoprotein (HPAFP); linkage studies with chromosome 4 markers [abstract]. Cytogenet Cell Genet 1984;37:469.
17. Staples J. Alphafetoprotein, cancer, and benign conditions. Lancet 1986;2:1277.
18. Greenberg F, Rose E, Alpert E. Hereditary persistence of alpha-fetoprotein. Gastroenterology 1990;98:1083-1085.
19. Feng YZ, Liu J, Zhou XR. Hereditary persistence of alpha-fetoprotein. Chin J Oncol 1994;16:54-55.
20. Mal F, Girard P, Gayet B. Augmentation importante et congénitale de ta concentration sérique de l'alpha-foetoprotéine: observation d'une familie. Gastroenterol Clin Biol 1997;21:903.
21. Schefer H, Mattmann S, Joss RA. Hereditary persistence of alpha-fetoprotein. Case report and review of the literature. Ann Oncol 1998;9:667-672.
22. Cochran PK, Chauvenet AR, Hart PS, de Graaf SS, Cushing B. Kroovand L, et al. Hereditary persistence of alpha-fetoprotein in a child with testicular germ cell tumor. Med Pediatr Oncol 1999;32(6):436-437.